Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 15, 2006Clinical Cancer Research

Guggulsterone Inhibits Osteoclastogenesis Induced by Receptor Activator of Nuclear Factor-κB Ligand and by Tumor Cells by Suppressing Nuclear Factor-κB Activation

View Full Paper
Ask AI
Bookmark
Share

Authors

HIHaruyo IchikawaThe University of Texas MD Anderson Cancer CenterBABharat B. AggarwalMax Super Speciality Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ichikawa et al. (2006) studied this question.

synapsesocial.com/papers/6a87d9f4f8efd6d7e4fb1ae7https://doi.org/10.1158/1078-0432.ccr-05-1749
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Protein Farnesyltransferase Inhibitor (SCH 66336) Abolishes NF-κB Activation Induced by Various Carcinogens and Inflammatory Stimuli Leading to Suppression of NF-κB-regulated Gene Expression and Up-regulation of Apoptosis2004 · 112 citations
  2. 2TRANCE (Tumor Necrosis Factor [TNF]-related Activation-induced Cytokine), a New TNF Family Member Predominantly Expressed in T cells, Is a Dendritic Cell–specific Survival Factor1997 · 869 citations
  3. 3Bone Resorption by Osteoclasts2000 · 4,003 citations
  4. 4G<scp>UGULIPID</scp>: A Natural Cholesterol-Lowering Agent2003 · 230 citations